The Research report Regenerative Medicine Market provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting market along with the forecasts of the revenue and market share analysis.
The cell-based products are expected to dominate the global market in 2016. Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
MarketsandMarkets published a report which says that the Regenerative medicine market is expected to reach USD 38.70 Billion, at a CAGR of 23.6%
Don’t miss out on business opportunities in Regenerative Medicine Market
Regenerative Medicine Market
Orthopedic & Musculoskeletal Disorders application will drive the growth of regenerative medicine market
Based on therapy, the market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Immunotherapy is the fastest growing segment in the global market, during the forecast period. This market is also segmented by application. By application, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing application market in the global market
Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65442579
Major Key players in the Regenerative Medicine Market;
Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).
Detailed Profile of Major Key Players ( Regenerative Medicine Market ):
Acelity (KCI Concepts) leads the global Regenerative medicine market in 2015. This company focusses in agreements and acquisitions to expand its market. For instance, Acelity partnered with Mediq (Netherlands), leading homecare and medical device delivery company. Under the terms of this agreement, Mediq will distribute Acelity’s advanced wound care and regenerative medicine portfolio in Denmark, Finland, Norway, and Sweden. With this partnership, Acelity gained access to Mediq’s specialized knowledge, expertise, and network in the region.
Download PDF( Regenerative Medicine Market )@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579
